Is Sugi Holdings stock a buy right now?

It looks balanced for long-term investors. The P/E is about 16.8 with ROE near 15.7% and a 0.92% yield. Our composite stock grade is B+ with a Buy tilt, while the latest company rating reads Neutral. Consider staggered entries and watch alliance execution in 2026.

How could the Trial Holdings partnership impact earnings?

Pharmacy tenants at Trial supercenters can lift traffic and add higher-value prescription sales. Cross-supplying health and beauty private label should support margin mix. Benefits depend on rollout speed, licensing, and shopper adoption. We expect clearer signs after initial 2026 sites and the April earnings guidance.

When is the next earnings date for Sugi Holdings?

The next scheduled earnings announcement is April 9, 2026. Management is likely to discuss early plans for in-store pharmacies with Trial, private-label expansion, and integration progress. Watch same-store sales, gross margin trend, and any updated capex or store pipeline details tied to the Chubu strategy.

What risks should investors monitor?

Key risks include price competition after the Seiyu acquisition, slower pharmacy rollout or staffing gaps, and regulatory changes around prescriptions. Supply chain or IT integration delays could also weigh on margins. Track traffic, ticket size, and guidance to confirm that synergy plans are pacing as expected.

What technical levels matter for Sugi Holdings stock?

The 50-day average near ¥3,670 and the 200-day near ¥3,472 are key supports. The 52-week high at ¥4,074 is resistance. With RSI around 44 and ADX near 11, momentum is modest. Mixed signals favor patience, partial positions, and clear stop levels to manage risk.

Global Market Insights

7649.T Stock Today: January 25 – Sugi‑Trial Alliance Targets Chubu Push

ByDanny Kontos January 25, 2026January 25, 2026

Sugi Holdings stock is in focus in Japan as the Trial Holdings partnership moves to execution following Trial’s full Seiyu acquisition. The tie-up covers in-store pharmacies at Trial supercenters, private-label cross-supply, and shared operations tech, aimed at a bigger Chubu footprint. At the last close, Sugi shares were ¥3,818 for 7649.T, within a 52-week range of ¥2,565.5 to ¥4,074. With a one-year gain of 48.6%, we review what the new alliance could mean for growth, margins, and valuation.